TITLE

The HIV Care Cascade and sub-analysis of those linked to but not retained in care: the experience from a tertiary HIV referral service in Dublin Ireland

AUTHOR(S)
McGettrick, P.; Ghavami-Kia, B.; Tinago, W.; Macken, A.; O'Halloran, J.; Lambert, J.S.; Sheehan, G.; Mallon, P.W.G.
PUB. DATE
May 2017
SOURCE
HIV Clinical Trials;May2017, Vol. 18 Issue 3, p93
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background:The HIV Care Cascade model can be used to measure how clinical services align with United Nations’ (UN) HIV treatment targets. Previous models have highlighted sequential losses at each step of the Cascade with a significant proportion being not retained in care (NRIC). Objective:We aimed to assess the feasibility of meeting the UN targets and assess factors associated with, and calculate the true proportion of those, NRIC. Methods:All people living with HIV who were linked to our service, one of three specialist HIV care providers in Dublin Ireland, from its establishment in 1993 to 1 December 2014, were included in the cohort and were categorized as linked to care, retained in care (RIC), on antiretroviral therapy (on ART), virally suppressed (HIV RNA <40copies/ml), and NRIC. An analysis of those NRIC was performed to categorize their current status through direct/indirect contact. Results:Of 1000 patients linked to care, 78.7% (n = 787) were RIC, of whom 91.5% (n = 720) were on ART, with 89.9% (n = 644) virally suppressed. Those RIC were more likely older (p = 0.006) and non-IVDU (p < 0.001). Of 213 (21.3%) NRIC, 56 (26.3%) emigrated, 27 (12.7%) transferred care, 15 (7.0%) stopped attending but were contactable, 38 (17.8%) died, and 77 (36.1%) were lost to follow-up. After revision, 10.5% of the cohort was confirmed as NRIC, with 6 of 15 defined as “stopped attending” re-linked to care following direct contact. Conclusions:Our HIV Care Cascade model demonstrates that the true numbers of patients NRIC may be significantly lower than previously estimated and once RIC, treatment goals approaching the United Nations Programme on HIV and AIDS targets are possible with 91.5% on treatment and almost 90% of those on treatment virally suppressed. That 40% reengaged following direct contact suggests benefit through regular monitoring and direct contact based on the HIV Care Cascade model.
ACCESSION #
123514989

 

Related Articles

  • Treatment for Adult HIV Infection. Hammer, Scott M.; Saag, Michael S.; Schechter, Mauro; Montaner, Julio S.G.; Schooley, Robert T.; Jacobsen, Donna M.; Thompson, Melanie A.; Carpenter, Charles C.J.; Fischl, Margaret A.; Gazzard, Brian G.; Gatell, Jose M.; Hirsch, Martin S.; Katzenstein, David A.; Richman, Douglas D.; Vella, Stefano; Yeni, Patrick G.; Volberding, Paul A. // JAMA: Journal of the American Medical Association;8/16/2006, Vol. 296 Issue 7, p827 

    Context Guidelines for antiretroviral therapy are important for clinicians worldwide given the complexity of the field and the varied clinical situations in which these agents are used. The International AIDS Society-USA panel has updated its recommendations as warranted by new developments in...

  • Should Australia consider opt-out HIV testing? Leidel, Stacy; McConigley, Ruth; Boldy, Duncan; Girdler, Sonya; Wilson, Sally // Australasian Medical Journal;2015, Vol. 8 Issue 1, p30 

    The article discusses the use of the opt-out testing technique for patients with undiagnosed HIV infection in Australia. There are several advantages in adopting the technique including the absence of stigma associated with formal HIV testing in the general population, the prevention of late HIV...

  • Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). Torti, Carlo; Raffetti, Elena; Donato, Francesco; Castelli, Francesco; Maggiolo, Franco; Angarano, Gioacchino; Mazzotta, Francesco; Gori, Andrea; Sighinolfi, Laura; Pan, Angelo; Cauda, Roberto; Scalzini, Alfredo; Quiros-Roldan, Eugenia; Nasta, Paola; Gregis, Giampietro; Benatti, Simone; Digiambenedetto, Simona; Ladisa, Nicoletta; Giralda, Mariarosaria; Saracino, Annalisa // International Journal of Epidemiology;Apr2017, Vol. 46 Issue 2, p1 

    No abstract available.

  • Modeling the HIV epidemic in Novgorod region, Russia. Azovtseva, O. V.; Arkhipov, G. S.; Arkhipova, E. I.; Smirnov, A. V.; Fishman, B. B. // Australasian Medical Journal;2016, Vol. 9 Issue 11, p422 

    The purpose of this study is design for predicting the epidemic process and to improve preventive measures, clinical examination and treatment of HIV-infected patients at both the regional and national level. Morbidity indicators for the last 25 years were studied; prevailing ways of...

  • Patient Enrolment into HIV Care and Treatment within 90 Days of HIV Diagnosis in Eight Rwandan Health Facilities: A Review of Facility-Based Registers. Kayigamba, Felix R.; Bakker, Mirjam I.; Fikse, Hadassa; Mugisha, Veronicah; Asiimwe, Anita; Loeff, Maarten F. Schim van der // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    Introduction: Access to antiretroviral therapy (ART) has increased greatly in sub-Saharan Africa. However many patients do not enrol timely into HIV care and treatment after HIV diagnosis. We studied enrolment into care and treatment and determinants of non-enrolment in Rwanda. Methods: Data...

  • Global News.  // American Journal of Public Health;Jun2017, Vol. 107 Issue 6, p823 

    The article presents global public health news briefs on topics including research which indicates that early-diagnosed HIV-positive patients might benefit from undergoing a combined therapy plan involving the HIVconsv vaccine and the drug romidepsin. Cuba's national intervention strategy for...

  • Physiotherapy intervention as a complementary treatment for people living with HIV/AIDS. Pullen, Sara D.; Chigbo, Nnenna Nina; Nwigwe, Emmanuel Chukwudi; Chukwuka, Chinwe J.; Amah, Christopher Chim; Idu, Stanley C. // HIV/AIDS - Research & Palliative Care;2014, Vol. 6, p99 

    Background: The advent of highly active antiretroviral therapy has dramatically extended the life expectancy of people living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome. Despite this increased longevity, HIV disease and its pharmacological treatment can cause...

  • Assessment of hematological adverse drug reactions to antiretroviral therapy in HIV positive patients at Kasturba Hospital Manipal. Pulagam, Poornima; Rajesh, Radhakrishnan; Vidyasagar, Sudha; Varma, Danturulu Muralidhar // BMC Infectious Diseases;2012 Supplement, Vol. 12 Issue Supplment 1, p1 

    The article presents a study on the hematological adverse drug reactions (ADRs) associated with highly active antiretroviral therapy in HIV positive patients in India. The authors investigate the casuality, incidence rate and severity pattern of hematological ADRs among HIV patients. The study...

  • Prevalence of depressive symptoms amongst highly active antiretroviral therapy (HAART) patients in AIDSRelief Uganda. Shumba, Constance; Atukunda, Ruth; Imakit, Richard; Memiah, Peter // Journal of Public Health in Africa;2013, Vol. 4 Issue 2, p84 

    There is limited data on the prevalence of depression in HIV and AIDS patients in Sub- Saharan Africa and little resources have been allocated to address this issue. Depression affects patient adherence to treatment and predisposes patients to resistance which poses a public health threat. It...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics